US Hematology Brand Lead - Navtemadlin Launch

Ipsen Biopharmaceuticals Inc.; Cambridge (MA); On-site; USD 232,000 - 320,000; Full time

Job summary

Ipsen Biopharmaceuticals Inc. is seeking a U.S. Hematology Brand Lead for Navtemadlin to shepherd the US launch within the Oncology franchise.

The role combines strategic brand leadership with cross-functional collaboration to deliver launch readiness, adoption, and sustainable growth in a complex hematology market. The successful candidate will bring 15+ years in commercial pharma/biotech with deep hematology/oncology expertise, and a proven track record of leading or centralizing U.S.

Qualifications

• Requires 15+ years in commercial pharma/biotech with U.S. marketing leadership
• Deep hematology/oncology experience with treatment pathways and cancer care ecosystem
• Proven track record leading U.S. product launches and launch readiness
• Strong scientific/clinical acumen to translate evidence into strategy
• Ability to lead cross-functional teams and manage in a matrixed organization

Responsibilities

• Own the U.S. brand strategy and launch roadmap for Navtemadlin.
• Lead end-to-end launch planning, including messaging, channels, and stakeholder engagement.
• Develop lifecycle plans with evidence generation and market access considerations.
• Manage cross-functional teams across Sales, Medical Affairs, Market Access, and Analytics.

Skills

Brand strategy

Launch leadership

Cross-functional leadership

Hematology/Oncology

Commercial pharma/biotech

English fluency

Education

BA/BS degree

MBA or advanced degree

Job description

Ipsen Biopharmaceuticals Inc. is seeking a U.S. Hematology Brand Lead for Navtemadlin to shepherd the US launch within the Oncology franchise.

The role combines strategic brand leadership with cross-functional collaboration to deliver launch readiness, adoption, and sustainable growth in a complex hematology market. The successful candidate will bring 15+ years in commercial pharma/biotech with deep hematology/oncology expertise, and a proven track record of leading or centralizing U.S.